INTERCEPT BLOOD, created in 2000 (United States), from 5 sister brands and 2214 competing brands. The INTERCEPT BLOOD brand is owned by Cerus Co., a company listed in New York. INTERCEPT BLOOD belongs to the Biotechnology business sector.
Investment simulator :
Portfolio valuation
Cerus Co.
(INTERCEPT BLOOD)
over 5 years*
USD 0.47